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O B J E C T I V E S The aim of this study was to determine the relationship between right atrial volume
index (RAVI) and right ventricular (RV) systolic and diastolic function, as well as long-term prognosis in
patients with chronic systolic heart failure (HF).
B A C KG ROUND RV dysfunction is associated with poor prognosis in patients with HF, although
echocardiographic assessment of RV systolic and diastolic dysfunction is challenging. The ability to
visualize the RA allows a quantitative, highly reproducible assessment of the RA volume that can be
indexed to body surface area.
METHOD S The ADEPT (Assessment of Doppler Echocardiography for Prognosis and Therapy) trial
enrolled 192 subjects with chronic systolic HF (left ventricular ejection fraction [LVEF] 35%). The RA
volume was calculated by Simpson’s method using single-plane RA area and indexed to body surface
area (RAVI). RV systolic function was graded as normal, mild, mild-moderate, moderate, moderately
severe, or severe dysfunction.
R E S U L T S In our study cohort, the mean RAVI was 28  15 ml/m2, and increased with worsening RV
systolic dysfunction, LVEF, and LV diastolic dysfunction (Spearman’s r  0.61, r  0.26, and r  0.51,
respectively; p  0.001 for all). RAVI correlated modestly with echocardiographic estimates of RV diastolic
dysfunction, including tricuspid early/late velocities ratio (Spearman’s r  0.34, p  0.0001), hepatic vein
systolic/diastolic ratio (Spearman’s r  0.26, p  0.001) but not tricuspid early/tricuspid annular early
velocities ratio (E/Ea) (Spearman’s r  0.12, p  0.11). Increasing tertiles of RAVI were predictive of death,
transplant, and/or HF hospitalization (log-rank p  0.0002) and remained an independent predictor of
adverse clinical events after adjusting for age, B-type natriuretic peptide, LV ejection fraction, RV systolic
dysfunction, and tricuspid E/Ea ratio (hazard ratio: 2.00, 95% conﬁdence interval: 1.15 to 3.58, p  0.013).
CONC L U S I O N S In patients with chronic systolic HF, RAVI is a determinant of right-sided systolic
dysfunction. This quantitative and reproducible echocardiographic marker provides independent risk
prediction of long-term adverse clinical events. (J Am Coll Cardiol Img 2009;2:527–34) © 2009 by the
American College of Cardiology Foundation
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528ight ventricular (RV) systolic dysfunction is a
common abnormality in patients with heart
failure (HF) (1,2), pulmonary hypertension
(2), pulmonary embolism, and chronic ob-
tructive pulmonary disease (3). Abnormalities in
V systolic function are often associated with poor
ong-term prognosis (4–6), and therefore, accurate
ssessment is important in risk prediction. How-
ver, precise clinical assessment of abnormalities in
V structure and performance is challenging,
rimarily because the morphology of the RV is
omplicated and indices of RV function are often
oorly visualized by standard echocardiographic
echniques.
The ability to visualize the right atrium (RA)
allows a quantitative, highly reproducible
assessment of the RA volume that can be
indexed to body surface area (7,8). We
hypothesized that RA volume can serve as
a quantitative marker of RV dysfunction
severity. The aim of our study is to deter-
mine the relationship between right atrial
volume index (RAVI) and echocardio-
graphic indices of left and right side sys-
tolic and diastolic performance, as well as
long-term prognosis for patients with
chronic systolic HF.
M E T H O D S
Study population. We enrolled 192 consec-
utive ambulatory patients in the ADEPT
(Assessment of Doppler Echocardiogra-
phy for Prognosis and Therapy) study who
were referred to the department of cardio-
vascular medicine at the Cleveland Clinic
for evaluation of symptomatic (New York
Heart Association [NYHA] functional
class II to IV) chronic systolic heart failure
9), in whom echocardiographic evaluation allowed
eliable measurement of RA volume. Eligible pa-
ients were 18 to 75 years of age, with left ventric-
lar ejection fraction (LVEF) 35%. Patients were
xcluded by a history of mitral stenosis or mitral
alve surgery, severe mitral regurgitation (3), or
evere aortic stenosis (peak velocity 4 m/s) or
ortic regurgitation. The investigators verified clin-
cal data collected from the hospital chart. B-type
atriuretic peptide (BNP) was measured by the
hristchurch assay, as previously described (9), with
alues slightly lower than commercial BNP assays.
dverse events (all-cause mortality, cardiac trans-
ate
ion
dex
lar
glantation, or HF hospitalization) were prospec- dively tracked by scheduled telephone follow-up and
alidated by chart review. This study was approved
y the Cleveland Clinic Institutional Review Board
nd all subjects provided informed consent.
ransthoracic echocardiography. Comprehensive
ransthoracic echocardiography was performed us-
ng commercially available HDI 5000 (Phillips
edical Systems, N.A., Bothell, Washington) and
cuson Sequoia (Siemens Medical Solutions USA,
nc., Malvern, Pennsylvania) machines. Two-
imensional and color Doppler imaging were per-
ormed in standard parasternal and apical views.
eft ventricular systolic and diastolic indexes were
cquired as previously outlined in the ADEPT trial
9). All images were stored on magneto-optical disc
nd were measured offline later by an independent
nvestigator who was blinded to the clinical data (9).
All measures of right-side heart structure and
erformance were averaged over 3 cardiac cycles (5
ycles for atrial fibrillation [AF]). RA area was
easured in the apical 4-chamber view at end
ystole. RAVI was calculated using Simpson’s
ethod, in the 4-chamber view, and indexed to
ody surface area (7,8). The RV was assessed in the
pical 4-chamber, parasternal short-axis and sub-
ostal views. RV systolic function was graded on a
cale from 0 to 5 based on a semiquantitative visual
stimate of normal, mild, mild-moderate, moder-
te, moderately severe, or severe dysfunction (9).
ight ventricular indexes were acquired over 10
onsecutive beats using sweep speeds of 50 and 100
m/s. With pulsed-wave Doppler, we acquired
ranstricuspid flow using a 1- to 2-mm sample
olume placed at the tricuspid leaflet tips in the
pical 4-chamber view and hepatic vein flow using
3- to 4-mm sample volume placed in the hepatic
ein 1 cm from the junction of the RA and hepatic
ein. Tricuspid annular tissue Doppler imaging
TDI) was acquired with standard pre-sets opti-
ized to eliminate background noise and enhance
issue signals using a 5-mm sample volume placed
t the lateral and tricuspid annulus in the
-chamber view. Measurements from pulsed-wave
oppler included transtricuspid peak E (early) and
(late) velocities, early deceleration time (DT),
epatic vein systolic and diastolic flows, and peak
ricuspid annular systolic early (Ea) and late (Aa)
elocities. The RV diastolic dysfunction was as-
essed by echocardiographic measures of tricuspid
elocities, including tricuspid E/A ratio, RA area,
nd hepatic vein systolic/diastolic (S/D) ratio. Be-
ause there is no prior classification scheme, RVB B R E V I A T I O N S
N D A C R O N YM S
NP B-type natriuretic
eptide
/A ratio tricuspid early/l
elocities ratio
/Ea ratio tricuspid
arly/tricuspid annular early
elocities ratio
F heart failure
R hazard ratio
V left ventricular
VEF left ventricular eject
raction
A right atrium
AVI right atrial volume in
OC receiver-operator
haracteristic
V right ventricle/ventricu
/D hepatic vein
ystolic/diastolic ratioiastolic dysfunction stage was arbitrarily defined
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529n the basis of these echocardiographic measures:
tage 0 (normal) was tricuspid E/A ratio 1 to 2 and
A area 15 cm2; stage I (abnormal relaxation)
as tricuspid E/A ratio 1; stage II (pseudonor-
al) was tricuspid E/A ratio 1 to 2 and RA area
15 cm2; and stage III (restrictive) was tricuspid
/A ratio 2.
tatistical analysis. RA volume and RAVI were
reated as non-normally distributed variables and
ere assessed by nonparametric methods. The
onckheere-Terpstra test was used to test trends in
AVI across RV systolic dysfunction severity, RV
iastolic dysfunction severity, and LV diastolic
ysfunction severity. Receiver-operator characteris-
ic (ROC) analysis was used to determine the
ensitivity and specificity of RAVI in predicting HF
isease severity. Optimal ROC cutoffs were chosen
t values maximizing the summation of sensitivity
nd specificity as provided by JMP 7.0 (SAS Insti-
ute, Cary, North Carolina). Spearman’s correlation
oefficient was used to evaluate significant relation-
hips between clinical and echocardiographic vari-
bles and RAVI. For linear regression analysis, a
tepwise variable selection procedure was used to
elect variables significantly related with RAVI with
probability of 0.1 to enter or leave. For outcomes
nalysis, Cox proportional hazards models included
AVI modeled as a continuous variable along with
ther known predictors (age, BNP, LVEF, and RV
ystolic dysfunction, LV diastolic dysfunction, and
eft atrial volume index). With a total of 192
atients (62 events), this study had a power of 80%
o detect a hazard ratio (HR) of 1.43 per standard
eviation of RAVI. The power computation was
ased on a type I error of 0.05. The proportional
azards assumption was verified with log[time]
ersus log(log[survival]) plots. The functional
orms of the predictors were assessed by checking
he martingale residuals. The goodness of fit was
ssessed by using the chi-square test. Time-
ependent ROC analysis was used to determine the
ensitivity and specificity of RAVI in predicting
dverse clinical events (10). A p value  0.05 was
onsidered statistically significant. Statistical analy-
es were performed using JMP 7.0 and SAS 9.1.3
SAS Institute).
E S U L T S
tudy population. Baseline clinical and echocardio-
raphic parameters are shown in Table 1. In our
tudy population, the overall mean RA volume was
7  31 ml, with mean RA volume higher in men mhan in women (64  31 ml vs. 40  24 ml,
espectively, p  0.0001). When these volumes
ere indexed to body surface area, the mean and
edian levels were 28.4  15.3 ml, and mean
AVI was 31  15 ml/m2 in men and 21  12
Table 1. Baseline Characteristics
Variable Value
Demographic data
Mean age, yrs 57 13
Male, % 72
NYHA functional class III to IV, % 41
Medical history, %
Ischemic heart failure etiology 41
History of hypertension 51
History of diabetes mellitus 26
History of atrial ﬁbrillation 24
Echocardiographic data
LVEF, % U 25 6
LV end-diastolic dimension, cm 6.4 0.9
LV end-diastolic volume index, ml/m
2
115 41
LV end-systolic volume index, ml/m2 87 35
LA volume index, ml/m2 42 17
PA systolic pressure, mm Hg 38 15
Diastolic stage I/II/III, % 40/26/34
Septal mitral annulus TDI
Sa wave 4.6 1.7
Ea wave 4.7 2.2
Aa wave 6.8 2.8
Mitral E/Ea ratio 19 12
RA area, cm2 20 7
RA volume index, ml/m2 28 15
Tricuspid Doppler ﬂow
E wave, cm/s 45 14
A wave, cm/s 39 12
Deceleration time, ms 206 60
E/A ratio 1.2 0.5
Lateral tricuspid annulus TDI
Sa wave, cm/s 9.9 3.4
Ea wave, cm/s 8.3 3.1
Aa wave, cm/s 11.5 4.9
Tricuspid E/Ea ratio 6.3 3.8
Hepatic vein peak S/D ratio 1.3 0.6
RV systolic dysfunction stage 3 26
Mitral regurgitation 3 9.4
Tricuspid regurgitation 3 6.3
Laboratory data
BNP, Christchurch assay, pg/ml 67 (27–158)
eGFR, ml/min/1.73m2 69 24
A late velocity; Aa annular late velocity; BNP B-type natriuretic peptide;
E  tricuspid early velocity; Ea  tricuspid annular early velocity; eGFR 
estimated glomerular ﬁltration rate; LA  left atrial; LV  left ventricular;
LVEF left ventricular ejection fraction; NYHA New York Heart Association;
PA  pulmonary artery; RA  right atrial; RV  right ventricular; S/D  sys-
tolic/diastolic; Sa  annular systolic velocity; TDI  tissue Doppler imaging.l/m2 in women (p 0.0001). Mean RAVI was 18

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5307 ml/m2 in patients with normal RV systolic
unction, and 15 5 ml/m2 in patients with normal
V diastolic function. Forty-seven (24%) of 192
atients had AF (35 paroxysmal, 4 permanent, 8
ersistent), and patients with AF had higher RAVI
34  17 ml/m2 vs. 27  14 ml/m2, p  0.0012).
In ROC analysis, RAVI 41.6 ml/m2 (optimal
OC cutoff) had a 68% sensitivity and a 92%
pecificity (p  0.0004) for predicting NYHA
unctional class III; RAVI 30.6 ml/m2 (optimal
OC cutoff) had a 78% sensitivity and a 77%
pecificity (p  0.0001) for predicting RV systolic
ysfunction stage 3; and RAVI 37.8 ml/m2
optimal ROC cutoff) had a 80% sensitivity and a
0% specificity (p  0.0002) for predicting RV
iastolic dysfunction stage 3.
ight ventricular systolic and diastolic function. Right
entricular systolic function was graded as normal in
8 (30%), mild in 44 (23%), moderate in 40 (21%),
oderate/severe in 29 (15%), and severe in 21
11%) subjects. As RV systolic dysfunction wors-
ned, RAVI increased significantly (Table 2, Fig.
). In multivariable correlation, RV systolic dys-
unction stage and RV diastolic dysfunction stage
ere significantly related to RAVI (Table 2). RAVI
lso showed significant univariable correlation with
nd Multivariable Correlation Analysis of Echocardiographic Varia
0.0001)
Univariable Analysis
Spearman’s r p Val
0.26 0.00
sion 0.14 0.05
n stage 0.51 0.00
stage 0.61 0.00
n stage 0.63 0.00
0.46 0.00
0.08 0.27
0.34 0.00
0.34 0.00
0.37 0.00
0.07 0.32
0.43 0.00
0.12 0.10
0.29 0.00
0.07 0.40
0.26 0.00
r abbreviations as in Table 1.ulmonary vein S/D ratio (Spearman’s r  0.50, i 0.0001) and BNP (Spearman’s r  0.50, p 
.0001).
Right ventricular diastolic function was defined
n 174 subjects, and was graded as stage 0 in 29
17%) subjects, stage 1 in 66 (38%), stage 2 in 69
40%), and stage 3 in 10 (6%). RAVI did not
orrelate with TDI tricuspid E/Ea ratio and mod-
stly correlated with tricuspid E/A ratio (r  0.34,
 0.0001) and hepatic vein S/D ratio (r0.26,
 0.001) in univariable analysis (Table 2). Sig-
ificant differences in RAVI were observed between
ifferent RV diastolic stages (Fig. 1).
utcome analysis of RAVI and RA systolic dysfunc-
ion. In our study population, there were 34 deaths,
6 deaths and/or transplant, and 62 deaths, trans-
lants, and/or HF hospitalization. In Kaplan-Meier
urvival analysis, increasing tertiles of RAVI were
trongly predictive of death, transplant, or HF
ospitalization over a mean follow-up of 36  20
onths (log-rank p  0.0002) (Fig. 2). Worsening
V systolic dysfunction grade (2 vs. 2) also
howed similar poor prognosis (log-rank p 
.0017) (Fig. 2); however, RV diastolic dysfunction
tage (2 vs. 2) was not associated with survival
log-rank p  0.97). In univariable and multivari-
ble Cox proportional hazards analysis, RAVI
odeled as a continuous variable remained an
s With Indexed Right Atrial Volume
Multivariable Analysis
Standardized  p Value
0 —
0 —
0 —
0.38 0.0001
0.42 0.0001
0 —
0 —
0 —
0 —
0 —
0 —
0 —
0 —
0 —
0 —
0 —Table 2. Univariable a ble
(Overall r  0.70, p <
Variable ue
LVEF 04
LV end-diastolic dimen 46
LV diastolic dysfunctio 01
RV systolic dysfunction 01
RV diastolic dysfunctio 01
PA systolic pressure 01
TV Doppler ﬂow
E wave 27
A wave 01
E/A ratio 01
TV TDI
Sa wave 01
Ea wave 31
Aa wave 01
TV E/Ea ratio 65
Hepatic vein
S wave 02
D wave 89
Peak S/D ratio 09ndependent predictor of poor outcomes after ad-
j
t
(
d
c
c
n
0
f
O
d
m
b
a
A
2
c
1
n
[
0
D
U
t
n
d
m
f
R
f
o
t
i
p
p
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 5 , 2 0 0 9
M A Y 2 0 0 9 : 5 2 7 – 3 4
Sallach et al.
RA in Chronic Systolic HF
531usting for age, BNP, LVEF, RV systolic dysfunc-
ion stage, and tricuspid E/Ea ratio (p  0.005)
Table 3). Plasma BNP level was also an indepen-
ent prognostic marker when these 6 variables were
ombined into the Cox model (p  0.009). In
ontrast, RV systolic dysfunction grade was a sig-
ificant predictor in univariable analysis (p 
.0002), but became nonsignificant after adjusting
or BNP levels (p  0.34).
utcome analysis of RAVI and AF. RAVI also pre-
icted adverse clinical events independent of AF in
ultivariate Cox proportional hazards analysis (Ta-
le 3). RAVI remained a significant predictor of
dverse clinical events in patients with and without
F (HR: 1.52 [95% confidence interval: 1.01 to
.18], p  0.047, n  47, and HR: 1.56 [95%
onfidence interval: 1.20 to 1.99], p  0.001, n 
45, respectively). In our population, AF itself was
A p<0.0001
RV Systolic Dysfunction Stage
Normal
(n=58)
10
20
30
40
50
60
70
Mild
(n=44)
Moderate
(n=40)
ModSevere
(n=29)
Severe
(n=21)
C p<0.0001
LV Diastoli
I
(n=75)
10
20
30
40
50
60
70
Figure 1. RAVI According to Severity of RV and LV Dysfunction
Indexed right atrial volume (RAVI) according to severity of (A) right
(C) left ventricular (LV) diastolic dysfunction stages. The box lines r
the 10th and 90th percentiles. Note the signiﬁcant differences in RA
dysfunction, and LV diastolic dysfunction stages.ot a predictor of adverse clinical events (HR: 1.34 t95% confidence interval: 0.76 to 2.28], p 
.3054).
I S C U S S I O N
ntil recently, the routine evaluation of RV func-
ion on transthoracic echocardiogram has been
eglected. In part, this neglect has been due to
ifficulties in visualization and quantitative assess-
ent of the RV. Additionally, accepted guidelines
or the quantification of both systolic and diastolic
V dysfunction remain poorly defined. RV systolic
unction is now emerging as an important predictor
f morbidity and mortality in congestive HF pa-
ients (4,11,12). Similarly, RV diastolic dysfunction
s also recognized as a common complication in this
opulation (1,2). In our study, RAVI was an inde-
endent predictor of mortality and HF hospitaliza-
p<0.0001
RV Diastolic Dysfunction Stage
0
(n=29)
10
0
20
30
40
50
60
70
I
(n=66)
II
(n=69)
III
(n=10)
ysfunction Stage
II
n=49)
III
(n=64)
tricular (RV) systolic dysfunction; (B) RV diastolic dysfunction; and
t the median and interquartile range, and the whiskers extend to
etween the various stages of RV systolic dysfunction, RV diastolicB
c D
(
ven
epor
VI bion, after adjusting for age, LVEF, BNP, RV
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532ystolic dysfunction, and tricuspid E/Ea ratio.
hus, despite limitations in quantifying RV dimen-
ions, echocardiographic assessment of RA size is
mportant in the prognosis of chronic HF.
For the study population, RAVI values are con-
istent with mean indexed RA volumes calculated
n prior studies that utilized a monoplane Simpson’s
ule (13,14). In a follow-up study, Lambertz et al.
15) calculated a significantly larger mean RAVI of
8  6 ml/m2 by employing an alternative RA
olume calculation utilizing 2 intersecting echocar-
iographic views. This technique correlated
trongly with RA volumes determined by angiog-
aphy, and the investigators concluded that mono-
lane volume determination from the apical
Log-rank p=0.0002
Days
250 500 750 1000 1250 1500
Log-rank p=0.0017
Days
Normal or Mild
RV Systolic Dysfunction
Moderate or Severe
RV Systolic Dysfunction
250 500 750 1000 1250 1500
r Survival Analysis Across Severity of RAVI and RV
nalysis across severity of indexed right atrial volume (RAVI) and
ystolic dysfunction over a mean follow-up of 36  20 months. (A)
AVI were strongly predictive of death, transplant, or heart failure
k p  0.0002); the third tertile of RAVI (32 ml/m2) showed the
oderate or severe RV systolic dysfunction were strongly predictive
r heart failure hospitalization compared with normal or mild RV
g-rank p  0.0017).-chamber view may underestimate RA size, as fnly a portion of the true volume is measured.
impson’s method of RA volume calculation omits
A vertical extension and the auricle (15). How-
ver, as RA volume was calculated after echocar-
iograms were performed, adequate subcostal views
ere not routinely available.
Our study also demonstrated the strong relation-
hip between RAVI and RV systolic dysfunction in
oth univariable and multivariable analysis. RV
ystolic dysfunction was noted in 70% of study
atients, the majority of whom demonstrated mild
r moderate hypokinesis. RV wall hypokinesis is
ndicated in lower RV ejection fraction and pulmo-
ary perfusion (16,17). Other echocardiographic
ethods to assess RV systolic dysfunction employ
ricuspid annular systolic excursion (18) and TDI
ricuspid annular systolic velocity (11). Animal
tudies suggest that RV pressure overload leading to
ncreasing RA size is more closely related to RV
iastolic dysfunction (19). Impaired RV contractil-
ty may cause compensatory elevated RAVI for
ncreasing blood volume reservoir, and result in an
nderperfused state with lower blood volume or
xygen delivery from the pulmonary circulation
20,21). The dilated RA size and depressed RV
jection function may present as reduced exercise
olerance (22).
Interestingly, the RAVI showed only a modest
orrelation with tricuspid E/A ratio and hepatic
ein S/D ratio, but did not correlate with the TDI
/Ea ratio. This suggests that RAVI may be more
eflective of the chronicity of RV diastolic function
ver time (similar to left atrial volume index) rather
han a measure of instantaneous diastolic function.
his also emphasizes the increased complexity of
easuring right-sided diastolic function and the
oor correlation of right atrial volume to RV filling
ressure due to the additional effect of RA stiffness
nd contractility (23). Conversely, RAVI was sig-
ificantly related to LV diastolic dysfunction. In our
atient population with chronic LV systolic dys-
unction, coexistent LV diastolic dysfunction may
xacerbate pulmonary edema and pressures, and
ransmit further retrograde to manifest as RV over-
oad and subsequent RA enlargement. Prior rela-
ionships between RV and LV diastolic measures
ad been demonstrated in dilated cardiomyopathy
atients (2). However, it is undetermined whether
eft-sided dysfunction precedes or follows right-
ided dysfunction. Therefore, the pathophysiology
f elevated RAVI in chronic HF is unresolved, andA
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533ine the etiology and effects of elevated RAVI on
mpaired cardiac function and hemodynamics.
tudy limitations. In spite of identifying a strong
elationship between RAVI and RV function, there
re several limitations to our study. Our study popu-
ation was relatively small. The RA volumes were
alculated using Simpson’s method from only 1 view,
he apical 4-chamber view. This view places the RA in
he far field, diminishing lateral resolution and ad-
ersely affecting visualization of the RA endocardium.
hereas the RV was assessed from multiple views,
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